Natera (NTRA) — insider trading
Health Care · NASDAQ
Natera (NTRA) has 331 reported SEC Form 4 insider transactions in our data, including 96 open-market sales among the most recent 100 (latest 2026-10-16).
Recent Form 4 transactions
Showing the 100 most recent of 331 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 98 | $409.34 | $40.1K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 80 | $406.06 | $32.5K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 90 | $403.70 | $36.3K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 60 | $401.62 | $24.1K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 280 | $400.68 | $112.2K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 142 | $398.95 | $56.7K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 80 | $409.36 | $32.7K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 35 | $406.63 | $14.2K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 50 | $405.15 | $20.3K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 90 | $404.25 | $36.4K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 280 | $401.29 | $112.4K | Form 4 |
| 2026-10-16 | Sheena Jonathan | Director, Other | Open-market sale | 215 | $399.34 | $85.9K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Option exercise / conversion (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,000 | $408.24 | $816.5K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 3,800 | $407.27 | $1.55M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,400 | $406.63 | $569.3K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 6,274 | $405.18 | $2.54M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 10,321 | $404.64 | $4.18M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 3,858 | $403.27 | $1.56M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 6,309 | $402.23 | $2.54M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 5,974 | $401.42 | $2.40M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,671 | $400.31 | $1.07M | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 793 | $399.31 | $316.7K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 600 | $398.09 | $238.9K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,100 | $397.16 | $436.9K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,900 | $396.30 | $753.0K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 300 | $394.40 | $118.3K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 800 | $393.47 | $314.8K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 300 | $391.58 | $117.5K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 600 | $390.21 | $234.1K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 714 | $389.84 | $278.3K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 286 | $388.32 | $111.1K | Form 4 |
| 2026-10-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Option exercise / conversion | 50,000 | $10.41 | $520.5K | Form 4 |
| 2026-10-07 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Bona fide gift | 6,000 | — | $0 | Form 4 |
| 2026-10-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 1,846 | $415.07 | $766.2K | Form 4 |
| 2026-10-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 954 | $413.11 | $394.1K | Form 4 |
| 2026-10-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 200 | $411.62 | $82.3K | Form 4 |
| 2026-10-01 | Chapman Steven Leonard | Director, Officer (CEO AND PRESIDENT) | Open-market sale | 1,273 | $413.31 | $526.1K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 220 | $390.53 | $85.9K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 1,935 | $389.71 | $754.1K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 1,341 | $388.76 | $521.3K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 2,846 | $387.74 | $1.10M | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 2,300 | $386.64 | $889.3K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 390 | $385.29 | $150.3K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 110 | $390.42 | $42.9K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 2,320 | $389.69 | $904.1K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 1,293 | $388.71 | $502.6K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 2,734 | $387.65 | $1.06M | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 2,175 | $386.71 | $841.1K | Form 4 |
| 2026-09-23 | Sheena Jonathan | Director, Other | Open-market sale | 400 | $385.10 | $154.0K | Form 4 |
| 2026-09-16 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Bona fide gift | 945 | — | $0 | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 200 | $356.87 | $71.4K | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 800 | $355.95 | $284.8K | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 450 | $354.91 | $159.7K | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 1,400 | $353.83 | $495.4K | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 100 | $349.05 | $34.9K | Form 4 |
| 2026-09-16 | Sheena Jonathan | Director, Other | Open-market sale | 200 | $348.03 | $69.6K | Form 4 |
| 2026-09-15 | Sheena Jonathan | Director, Other | Open-market sale | 6,000 | $350.07 | $2.10M | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,000 | $350.01 | $700.0K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 800 | $351.25 | $281.0K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 14,500 | $350.81 | $5.09M | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 4,206 | $349.51 | $1.47M | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 8,094 | $348.65 | $2.82M | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,700 | $347.81 | $939.1K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,122 | $346.68 | $389.0K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,700 | $345.38 | $932.5K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 5,839 | $344.49 | $2.01M | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,240 | $343.56 | $769.6K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,956 | $342.18 | $669.3K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,813 | $341.41 | $619.0K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,549 | $340.25 | $867.3K | Form 4 |
| 2026-09-15 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,481 | $339.24 | $502.4K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 4,064 | $342.51 | $1.39M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,700 | $341.35 | $921.6K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,000 | $340.31 | $680.6K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,100 | $339.37 | $712.7K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,400 | $338.30 | $473.6K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,207 | $337.17 | $744.1K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 8,459 | $336.27 | $2.84M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 3,754 | $335.18 | $1.26M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,818 | $334.24 | $941.9K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 2,246 | $333.07 | $748.1K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,000 | $332.02 | $332.0K | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 3,494 | $330.98 | $1.16M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 6,206 | $330.05 | $2.05M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 6,015 | $329.12 | $1.98M | Form 4 |
| 2026-09-14 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,537 | $328.09 | $504.3K | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 1,300 | $329.62 | $428.5K | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 15,764 | $328.95 | $5.19M | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 17,933 | $327.97 | $5.88M | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 10,556 | $327.14 | $3.45M | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 3,647 | $326.11 | $1.19M | Form 4 |
| 2026-09-11 | Rabinowitz Matthew | Director, Officer (EXECUTIVE CHAIRMAN) | Open-market sale | 800 | $325.01 | $260.0K | Form 4 |
| 2026-09-02 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 15,160 | $326.89 | $4.96M | Form 4 |
| 2026-09-01 | Chapman Steven Leonard | Director, Officer (CEO AND PRESIDENT) | Open-market sale | 1,698 | $320.99 | $545.0K | Form 4 |
| 2026-09-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 600 | $321.91 | $193.1K | Form 4 |
| 2026-09-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 1,400 | $320.92 | $449.3K | Form 4 |
| 2026-09-01 | Moshkevich Solomon | Officer (PRESIDENT, CLINICALDIAGNOSTICS) | Open-market sale | 1,000 | $319.76 | $319.8K | Form 4 |
| 2026-08-10 | Fesko John | Officer (PRESIDENT, CHIEF BUS. OFFICER) | Open-market sale | 6,517 | $321.53 | $2.10M | Form 4 |
| 2026-08-10 | Sheena Jonathan | Director, Other | Open-market sale | 6,000 | $325.32 | $1.95M | Form 4 |
Ask the chat about NTRA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Natera (NTRA).
Last updated 2026-10-16 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.